DEXLEVO
PrivateLast Round
VC Round
Nov 25, 2021
Est. Valuation
$230.57M
Total Funding Raised
$13.61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DEXLEVO is a biotechnology company that develops and manufactures medical aesthetic products, including its proprietary liquid PCL-based collagen stimulator, GOURI.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DEXLEVO Comparables
Compare DEXLEVO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Koru Pharma Co., Ltd. | 83% | |
| Suneva Medical | 81% | |
| Huadong Medicine Co., Ltd. | 78% |
For institutional investors. Book with your work email.
DEXLEVO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 25, 2021 | ||||
| Series B | Sep 1, 2018 | ||||
| Series A | May 23, 2016 |
For institutional investors. Book with your work email.
DEXLEVO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series A, Series B, VC Round |
| Hyundai Technology Investment | VC Round |
| HB Investment | Series A |
| Magna Investment | Seed, Series B, VC Round, Series A |
| Shinhan Capital Co., Ltd. | VC Round, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
Grew 21% QoQ from 19 to 23 employees.
- Aug 21, 2026
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
DEXLEVO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DEXLEVO's valuation, stock price, and market status.
Is DEXLEVO a public or private company?
DEXLEVO is a private company.
What is the current stock price of DEXLEVO?
DEXLEVO is a private company, so its shares have no public market price. Caplight tracks DEXLEVO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DEXLEVO worth (valuation)?
DEXLEVO's valuation is estimated at $230.6M based on funding round data.
Can I buy DEXLEVO stock?
DEXLEVO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DEXLEVO's last funding round?
DEXLEVO's most recent funding round was VC Round on November 25, 2021.
Who are the main investors in DEXLEVO?
Key investors in DEXLEVO include Smilegate Investment, Magna Investment.
Will DEXLEVO IPO soon?
No public IPO plans have been announced for DEXLEVO.
How can I track DEXLEVO secondary market activity?
Caplight tracks bids, offers, and trades in DEXLEVO's shares on secondary markets.